Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$44.2 - $50.2 $2.68 Million - $3.04 Million
-60,604 Reduced 42.91%
80,646 $3.67 Million
Q2 2023

Aug 11, 2023

BUY
$31.86 - $67.26 $4.5 Million - $9.5 Million
141,250 New
141,250 $6.12 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $1.61 Million - $2.52 Million
-22,314 Reduced 33.0%
45,304 $3.28 Million
Q2 2022

Aug 12, 2022

SELL
$87.2 - $114.05 $996,783 - $1.3 Million
-11,431 Reduced 14.46%
67,618 $7.26 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $1.71 Million - $2.25 Million
18,110 Added 29.72%
79,049 $8.77 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $2.53 Million - $2.95 Million
21,200 Added 53.35%
60,939 $7.8 Million
Q3 2021

Nov 12, 2021

SELL
$109.17 - $142.35 $1.64 Million - $2.14 Million
-15,000 Reduced 27.4%
39,739 $5.29 Million
Q2 2021

Aug 13, 2021

SELL
$100.34 - $115.69 $2.49 Million - $2.87 Million
-24,787 Reduced 31.17%
54,739 $5.92 Million
Q1 2021

May 14, 2021

SELL
$101.51 - $125.27 $466,235 - $575,365
-4,593 Reduced 5.46%
79,526 $8.38 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $506,434 - $621,307
-5,897 Reduced 6.55%
84,119 $8.75 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $362,536 - $461,020
-4,984 Reduced 5.25%
90,016 $7.71 Million
Q2 2020

Aug 13, 2020

BUY
$48.02 - $79.04 $4.56 Million - $7.51 Million
95,000 New
95,000 $6.96 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.